Bio-Rad Laboratories Inc. CI A (BIO) News

Bio-Rad Laboratories Inc. CI A (BIO): $351.55

6.90 (-1.92%)

POWR Rating

Component Grades








Filter BIO News Items

BIO News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

BIO News Highlights

  • BIO's 30 day story count now stands at 4.
  • Over the past 26 days, the trend for BIO's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
  • COLB, LPG and RAD are the most mentioned tickers in articles about BIO.

Latest BIO News From Around the Web

Below are the latest news stories about BIO-RAD LABORATORIES INC that investors may wish to consider to help them evaluate BIO as an investment opportunity.

ResMed (RMD) Stock Jumps 3.8%: Will It Continue to Soar?

ResMed (RMD) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Yahoo | September 28, 2023

New Strong Sell Stocks for September 19th

BIO, LPG and COLB have been added to the Zacks Rank #5 (Strong Sell) List on September 19, 2023.

Yahoo | September 19, 2023

Unveiling Bio-Rad Laboratories (BIO)'s Value: Is It Really Priced Right? A Comprehensive Guide

A deep dive into the intrinsic value of Bio-Rad Laboratories, shedding light on its current market value.

Yahoo | September 8, 2023

3 Beaten-Down Biotech Stocks Bound for a Bounce Back

Biotech stocks are still below their post-pandemic peaks.

John Blankenhorn on InvestorPlace | September 2, 2023

Estimating The Intrinsic Value Of Bio-Rad Laboratories, Inc. (NYSE:BIO)

Key Insights The projected fair value for Bio-Rad Laboratories is US$399 based on 2 Stage Free Cash Flow to Equity...

Yahoo | August 29, 2023

Bio-Rad to Participate in Fireside Chat During Wells Fargo’s 2023 Healthcare Conference

HERCULES, Calif., August 28, 2023--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today announced that the company’s management will participate in a fireside chat event during Wells Fargo’s 2023 Healthcare Conference on Thursday, September 7 at 11:00 AM Eastern Time (8:00 AM Pacific Time).

Yahoo | August 28, 2023

New Strong Sell Stocks for August 18th

BIO, REFI and GPK have been added to the Zacks Rank #5 (Strong Sell) List on August 18, 2023.

Yahoo | August 18, 2023

Mason Hawkins' Q2 2023 13F Filing Update: Top Trades and Portfolio Overview

Renowned value investor Mason Hawkins recently disclosed his firm's portfolio updates for the second quarter of 2023, which ended on June 30, 2023.

Yahoo | August 14, 2023

New Strong Sell Stocks for August 9th

BWA, ARR and BIO have been added to the Zacks Rank #5 (Strong Sell) List on August 9, 2023.

Yahoo | August 9, 2023

Is Bio-Rad Laboratories (BIO) Significantly Undervalued? An In-depth GF Value Analysis

On August 4, 2023, Bio-Rad Laboratories Inc (NYSE:BIO) saw a daily gain of 3.5%, despite a reported Loss Per Share of 6.54. Let's uncover the financial intricacies of Bio-Rad Laboratories (NYSE:BIO). Headquartered in Hercules, California, Bio-Rad Laboratories Inc is a leading player in the clinical diagnostics and life sciences markets.

Yahoo | August 4, 2023

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!